Revelation Biosciences (REVB) Reports Q4 Loss of $2.46
Tweet
Share
E-mailGet Alerts REVB Hot Sheet
Join SI Premium – FREE
Revelation Biosciences (NASDAQ: REVB) reported Q4 EPS of ($2.46).
For earnings history and earnings-related data on Revelation Biosciences (REVB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
